Revision as of 09:17, 18 August 2024 edit Tamzin (talk \| contribs) Autopatrolled, Administrators 69,010 edits shuffle Tag: Visual edit: Switched ← Previous edit		Revision as of 23:33, 19 August 2024 edit undo Tamzin (talk \| contribs) Autopatrolled, Administrators 69,010 edits replace Tag: Visual edit Next edit →
Line 5: * [[Feminizing hormone therapy]] – for [[Trans woman\|transgender women]] or [[transfeminine]] people; consists of [[estrogen (medication)\|estrogens]] with or without [[antiandrogens]]. Eligibility for ~~transgender hormone therapy~~GAHT may require an assessment for [[gender dysphoria]] or persistent gender incongruence; or many medical institutions now use an [[informed consent]] model, which ensures patients are informed of the procedure process, including possible benefits and risks, while removing many of the historical barriers needed to start hormone therapy. Treatment guidelines for therapy have been developed by several medical associations. [[Non-binary people]] may also engage in hormone therapy in order to achieve a desired balance of sex hormones or to help align their bodies with their gender identities.<ref name="Ferguson">{{cite journal\|vauthors=Ferguson JM\|title=What It Means to Transition When You're Non-Binary\|journal=Teen Vogue\|date=November 30, 2017\|url=https://www.teenvogue.com/story/non-binary-transitioning\|access-date=March 20, 2018\|archive-date=December 13, 2019\|archive-url=https://web.archive.org/web/20191213162006/https://www.teenvogue.com/story/non-binary-transitioning\|url-status=live}}</ref> Many transgender people obtain hormone therapy from a licensed health care provider and others [[DIY transgender hormone therapy\|obtain and self-administer hormones]]. Line 218: ===Fertility consideration=== ~~Transgender hormone therapy~~GAHT may limit fertility potential.<ref name="T'Sjoen_2013">{{cite journal \| vauthors = T'Sjoen G, Van Caenegem E, Wierckx K \| title = Transgenderism and reproduction \| journal = Current Opinion in Endocrinology, Diabetes, and Obesity \| volume = 20 \| issue = 6 \| pages = 575–579 \| date = December 2013 \| pmid = 24468761 \| doi = 10.1097/01.med.0000436184.42554.b7 \| s2cid = 205398449 }}</ref> Should a transgender individual choose to undergo [[gender-affirming surgery]], their fertility potential is lost completely.<ref name="De_Sutter_2001">{{cite journal \| vauthors = De Sutter P \| title = Gender reassignment and assisted reproduction: present and future reproductive options for transsexual people \| journal = Human Reproduction \| volume = 16 \| issue = 4 \| pages = 612–614 \| date = April 2001 \| pmid = 11278204 \| doi = 10.1093/humrep/16.4.612 }}</ref> Before starting any treatment, individuals may consider fertility issues and [[fertility preservation]]. Options include [[semen cryopreservation]], [[oocyte cryopreservation]], and [[ovarian tissue cryopreservation]].<ref name="T'Sjoen_2013" /><ref name="De_Sutter_2001" /> A study presented at ENDO 2019 (the [[Endocrine Society]]'s conference) shows that even after one year of treatment with testosterone, a [[transgender]] man can preserve his fertility potential.<ref>{{Cite web \|title=Ovary function is preserved in transgender men at one year of testosterone therapy \|work=Endocrine Society \|url=https://www.endocrine.org/news-and-advocacy/news-room/2019/endo-2019--ovary-function-is-preserved-in-transgender-men-at-one-year-of-testosterone-therapy \|access-date=25 March 2019 \|date=23 March 2019 \|archive-date=22 May 2022 \|archive-url=https://web.archive.org/web/20220522015341/https://www.endocrine.org/news-and-advocacy/news-room/2019/endo-2019--ovary-function-is-preserved-in-transgender-men-at-one-year-of-testosterone-therapy \|url-status=live }}</ref>

Gender-affirming hormone therapy: Difference between revisions